|
| Status |
Public on Aug 22, 2018 |
| Title |
Time series gene expression in critically ill patients: PREVAIL study |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
The PREVAIL study was a Phase II/III randomized controlled trial examining the use of lactoferrin to prevent nosocomial infections in critically ill patients undergoing mechanical ventilation.
Gene expression data was generated from a consecutive subset of patients at the lead study site. We used the Affymetrix PrimeView array to generate expression data at various time points during the ICU stay.
|
| |
|
| Overall design |
Time series gene expression profiling of critically ill patients undergoing mechanical ventilation, who were enroled in the PREVAIL study
|
| |
|
| Contributor(s) |
Maslove DM, Muscedere J |
| Citation(s) |
30015668 |
| |
| Submission date |
Aug 16, 2018 |
| Last update date |
Aug 22, 2018 |
| Contact name |
David M Maslove |
| E-mail(s) |
david.maslove@queensu.ca
|
| Organization name |
Queen's University
|
| Department |
Critical Care Medicine
|
| Lab |
CONDUIT Lab
|
| Street address |
76 Stuart St.
|
| City |
Kingston |
| State/province |
Ontario |
| ZIP/Postal code |
K7L 2V7 |
| Country |
Canada |
| |
|
| Platforms (1) |
| GPL16043 |
GeneChip® PrimeView™ Human Gene Expression Array (with External spike-in RNAs) |
|
| Samples (209)
|
|
| Relations |
| BioProject |
PRJNA486363 |
Less...
More...